ArticleTheranostics2018

Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling.

Laurel A Grisanti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.